Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Hose

Showing results (131-140 of 189) with videos related to

Pageof 19
Sort By:
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Cancer Research Communications|April 10, 2024
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment DynamicsMartin Kuric, Susanne Beck, Doris Schneider, et al.
Blood|April 14, 2005
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureJérôme Moreaux, Friedrich W Cremer, Thierry Reme, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiationMichel Jourdan, Anouk Caraux, Gersende Caron, et al.
Blood Advances|October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myelomaTilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Haematologica|October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaDirk Hose, Thierry Rème, Thomas Hielscher, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.
Blood|February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorAnne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Haematologica|May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantationMaximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Pageof 19

Showing results (131-140 of 189) with videos related to

Sort By:
Pageof 19
Blood|March 21, 2009
Induction of angiogenesis by normal and malignant plasma cellsDirk Hose, Jérôme Moreaux, Tobias Meissner, et al.
Cancer Research Communications|April 10, 2024
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment DynamicsMartin Kuric, Susanne Beck, Doris Schneider, et al.
Blood|April 14, 2005
The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signatureJérôme Moreaux, Friedrich W Cremer, Thierry Reme, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiationMichel Jourdan, Anouk Caraux, Gersende Caron, et al.
Blood Advances|October 18, 2018
Cytogenetic intraclonal heterogeneity of plasma cell dyscrasia in AL amyloidosis as compared with multiple myelomaTilmann Bochtler, Maximilian Merz, Thomas Hielscher, et al.
Haematologica|October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaDirk Hose, Thierry Rème, Thomas Hielscher, et al.
Frontiers in Immunology|December 26, 2022
The BLM helicase is a new therapeutic target in multiple myeloma involved in replication stress survival and drug resistanceSara Ovejero, Elena Viziteu, Laure Dutrieux, et al.
Cancer Research|December 21, 2017
Loss of RASSF4 Expression in Multiple Myeloma Promotes RAS-Driven Malignant ProgressionEva De Smedt, Ken Maes, Stefaan Verhulst, et al.
Blood|February 21, 2009
The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptorAnne Catherine Sprynski, Dirk Hose, Laurent Caillot, et al.
Haematologica|May 13, 2017
Longitudinal fluorescence <i>in situ</i> hybridization reveals cytogenetic evolution in myeloma relapsing after autologous transplantationMaximilian Merz, Anna Jauch, Thomas Hielscher, et al.
Pageof 19